4DX is a tech company and their main product have little reliance on supply chain, costs etc. Therefore 4DX is an easier sell to potential investors. But my question is the revenue and I think it is fairly priced now.
CYC has an imaging agent that needs to be manufactured, therefore harder to get approval and manufacture in addition to costs. Also CYC hasn't scaled well even though they started dominating the Canada market so they have disappointed investors and I guess everyone is still skeptical that CYC will turn a profit in the US.
However, it is hoped that going into the US they will see some profit due to the larger market and all those endorsements from US nuclear medicine community.
I'm not going to add given the price action but not ready to give up either.
CYC Price at posting:
$1.96 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)